Best-selling author Abraham Verghese, MD, will present the Keynote Lecture during the Opening Session of ACR Convergence 2022. As attendees gather in person for the first time since 2019, he said it is necessary to acknowledge the unprecedented period of struggle and valor experienced across the healthcare industry amid COVID-19.
Omic technologies are revealing disease subtypes and molecular targets that allow for more targeted and effective treatment for rheumatic disease. Andrea Fava, MD, will discuss the molecular dissection of lupus nephritis through urine proteomics in a session on precision medicine.
The deadline to claim CME credit and MOC points for in-person and virtual participation in the 2022 meeting is November 11, 2023.
Graduate student Chris Dunn will discuss the poster “Radiographic Osteoarthritis Progression Can Be Predicted via Pyrosequencing Analysis of Baseline Peripheral Blood” in a Saturday afternoon Ignite Talk.
Michelle Barraclough, PhD, will discuss the poster “Evolution of Subjective Cognitive Impairment Over Time in SLE Patients: Bayesian Longitudinal Item Response Theory Modelling” in a Sunday morning Ignite Talk.
Jose A. Gómez-Puerta, MD, PhD, MPH, will discuss the poster “Vaccination Against SARS-CoV-2 in Patients with Systemic Autoimmune Diseases: A Safety Report from EULAR COVAX Registry” in a Sunday afternoon Ignite Talk.
Ardy Fenando, MD, will discuss the poster “Autonomic Dysfunction in Sjögren’s Disease” in a Monday afternoon Ignite Talk.
Three plenary sessions over three days will highlight the latest discoveries, cutting-edge technology, emerging trends, and new clinical approaches for rheumatologic disease. The goal of all of the included studies is to improve upon the work being done in the field on behalf of patients, explained Zsuzsanna McMahan, MD, MHS.
Carol Langford, MD, MHS, will discuss cutting-edge advancements in clinical science from the past year, including new approaches to rheumatoid arthritis, lupus, spondyloarthritis, and myositis treatment. John Varga, MD, will discuss emerging developments in basic science, including single-cell RNA sequencing and other high-throughput technologies.
The convergence between rheumatology and infectious disease presented by COVID-19 continues to surprise patients, clinicians, researchers, industry, regulators, and other stakeholders. Stephen Saw, PharmD, BCIDP, is among the experts who will discuss the ongoing implications of this disease on rheumatology.